Trials / Completed
CompletedNCT01695876
A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD), Food Effect of AMG 357 in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 58 (actual)
- Sponsor
- Amgen · Industry
- Sex
- All
- Age
- 25 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
Study to evaluate the safety, tolerability, PK, PD, and food effect of AMG 357 in healthy subjects
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AMG 357 | Oral administration available in varying dose strength. |
| DRUG | Placebo | Matching placebo to AMG 357 containing no active drug |
Timeline
- Start date
- 2012-10-01
- Primary completion
- 2014-09-01
- Completion
- 2014-10-01
- First posted
- 2012-09-28
- Last updated
- 2015-03-04
Locations
3 sites across 1 country: New Zealand
Source: ClinicalTrials.gov record NCT01695876. Inclusion in this directory is not an endorsement.